Silver as an investment

Category Archives: Bloomberg L.P.

Anbang? Evergrande? Or Does HNA’s Bond Sale Mark The Beginning Of China’s Minsky Moment?

We know… there are several candidates to choose from. For example… It might be Anbang – the acquisitive insurance behemoth – see “Anbang Just Became A ‘Systemic Risk’: Revenues Crash As Its Chairman Is “Detained” It might be China Evergrande – the developer of “ghost” properties and described by J Capital’s, Anne Stevenson-Yang as “the […]

Deutsche Bank Trading Revenue Plunges 30% As CEO’s Time Running Out

Deutsche Bank’s Q3 2017 revenues were €6.78 billion, below market expectations of €6.88 billion. The share price fell 2.7% shortly after the European market open. The problem – like the previous quarter – was a bigger-than-expected drop in trading revenues. Trading revenue was down 30% year-on-year to €1.512 billion versus €2.162 billion in Q2 2017. […]

How Much Is Equity Research Actually Worth? Probably Less Than You Thought

Over the past several months, investment banks all across Europe have scrambled to put a price tag on their equity research after years of giving it way as a ‘freebie’ in return for trading commissions. Of course, for wall street’s titans of finance, you know, the same guys who will look you straight in the […]

‘Shocker’ Of The Day: ‘Tech’ Company That Buys Movie Tickets For $10 And Sells Them For $0.33 May Not Survive

Over the past 4 weeks, the stock of a tiny New York based “IT service management” company, Helios & Matheson Analytics, Inc., has surged just over 1,300% after announcing plans to purchase a majority stake of an “innovative and disruptive technology company” called MoviePass at a $210 million valuation. So how exactly does MoviePass, the […]

After Quietest September Ever, Stocks Face Ominous ‘Curse Of 7’ In Q4

After the quietest September in history for U.S. stocks… Things may about to get a little more exciting – entering the final months of 2017, that last digit doesn’t bode well, if history is any indication. As Bloomberg reports, some of the biggest fourth-quarter declines in the Dow Jones Industrial Average have occurred in years ending […]

VIX Set For Calmest September In History (Despite Nukes, Fed, Quakes, And Storms)

September has seen… More missile tests from a nuclear-capable nation than ever before. The biggest storms ever in America (a quarter of all Atlantic Cat 5 landfalls on record have occurred in the last two weeks). The worst quake in Mexico in over 30 years. US threats to cut China from the global financial system. […]

Tesla Upsizes Junk Bond Offering After Excess Demand

There’s covenant-lite and then there’s “zero covenant” junk debt, and moments ago Tesla just sold $1.8 billion of the former, upsizing what was previously expected to be a $1.5 billion issue. The deeply junk “B3/B-” rated bond was priced at par to yield 5.25%, with Goldman – who famously slashed its Tesla price target to […]

Wall Street Strategists Forecast Most-Bearish Second Half Since 1999

Despite a hiccup in the last week or so, global stocks survived as the best-performing asset class of the year (with the MSCI All-Country World Index wrapping up its best first half in 19 years)… But, as Bloomberg reports, Wall Street strategists are fighting historic odds when urging investors not to chase the rally in the U.S. […]

Trump Budget Cuts Hit As State Department Imposes New Hiring Freeze

In an effort to support President Trump’s plans to cut the State Department budget by about one-third in fiscal year 2018, Secretary of State Rex Tillerson has imposed a new freeze on hiring. As a reminder, President Trump instigated an across-the-board hiring freeze in his first days as President, then lifted it in April in […]

Trump Preparing Executive Order On Drug Prices; Spec Pharma Stocks Slide To One Month Lows

Specialty pharma stocks are dropping – again – on news that the Trump administration is preparing an executive order – again – targeting lower U.S. drug costs. Bloomberg reports that the order addressing the sensitive campaign issue could come within weeks and has been largely left out of Republican legislative efforts in Congress, until now. […]